Autoimmune Bullous Disorders Associated With Immune Checkpoint Inhibitors: A Retrospective Review of a Single Center Cohort Over the Past Decade. (PubMed, Clin Exp Dermatol) - Oct 1, 2026 - "ICI-associated AIBDs are uncommon but clinically significant complications. Most patients in our cohort continued ICI therapy during management of their irAIBD, while others required temporary or permanent interruption. These findings highlight the importance of prompt recognition and multidisciplinary management of these uncommon toxicities."
Checkpoint inhibition • Journal • Retrospective data • Bullous Pemphigoid • Dermatology • Dermatopathology • Immunology • Infectious Disease • Lichen Planus • Lung Cancer • Melanoma • Oncology • Pruritus • Septic Shock • Solid Tumor • CTLA4 • PD-1
|
|
Anagha Bangalore-Kumar; Austin Todd; Deborah Cull; Disha Chakraborty; Julia Lehman; Katherine Holder; Sindhuja Sominidi Damodaran; Sydney Proffer
|